{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:31:54Z","timestamp":1775273514224,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle disorders and non-acute IT-IEM such as phenylketonuria (PKU) and their treatment have a major impact on the life of affected children and families. Yet patients\u2019 and parents\u2019 perspectives on the burdens of IT-IEM and its effects on everyday functioning and well-being have rarely been addressed. Patient- and observer-reported outcomes (PROs\/ObsROs) are critically important to evaluate and target health care and treatment efficacy. Therefore, it is mandatory to define PROs\/ObsROs relevant to patients with IT-IEM, their families, and health care professionals and to provide valid, standardised and reliable measuring instruments. To achieve consensus we performed a two-round, electronic-based modification of a Delphi survey including 27 parents of affected children, nine teenage patients and 35 health professionals (physicians, nutritionists, psychologists). The final set of PROs\/ObsROs was discussed and defined in an online consensus meeting with a subsample of three health professionals, three parents and two patients. For this final set, appropriate measures (PROMs\/ObsROMs) were assembled.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventeen PROs\/ObsROs constitute the final core set for paediatric IT-IEM. They cover social (e.g. social participation), emotional (e.g. positive affect), and disease-related aspects (e.g. attitude towards treatment) of patients\u2019 lives as well as the experience of parents (e.g. parental stress).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>To promote a holistic treatment approach, this consensus-driven set of relevant PROs\/ObsROs should be incorporated into daily IT-IEM care and considered as the key psychological outcomes in clinical trials. We have identified existing\u2014psychometrically and contextual\u2014appropriate PROMs\/ObsROMs with open access to facilitate this process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02183-2","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T12:03:03Z","timestamp":1643457783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Key patient-reported outcomes in children and adolescents with intoxication-type inborn errors of metabolism: an international Delphi-based consensus"],"prefix":"10.1186","volume":"17","author":[{"given":"Florin","family":"B\u00f6sch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina A.","family":"Zeltner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias R.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0590-678X","authenticated-orcid":false,"given":"Martina","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Landolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"issue":"4","key":"2183_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/ped.12089","volume":"55","author":"TF Eminoglu","year":"2013","unstructured":"Eminoglu TF, Soysal SA, Tumer L, Okur I, Hasanoglu A. Quality of life in children treated with restrictive diet for inherited metabolic disease. Pediatr Int. 2013;55(4):428\u201333. https:\/\/doi.org\/10.1111\/ped.12089.","journal-title":"Pediatr Int"},{"issue":"1","key":"2183_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/JIMD.12301\/FORMAT\/PDF","volume":"44","author":"F B\u00f6sch","year":"2021","unstructured":"B\u00f6sch F, Landolt MA, Baumgartner MR, et al. Health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism: analysis of an international data set. J Inherit Metab Dis. 2021;44(1):215\u201325. https:\/\/doi.org\/10.1002\/JIMD.12301\/FORMAT\/PDF.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2183_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"US Department of Health and Human Services Food and Drug Administration","year":"2006","unstructured":"US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4(1):1\u201320. https:\/\/doi.org\/10.1186\/1477-7525-4-79.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"2183_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s11606-014-2892-z","volume":"29","author":"E Basch","year":"2014","unstructured":"Basch E, Bennett AV. Patient-reported outcomes in clinical trials of rare diseases. J Gen Intern Med. 2014;29(3):801\u20134. https:\/\/doi.org\/10.1007\/s11606-014-2892-z.","journal-title":"J Gen Intern Med"},{"key":"2183_CR5","doi-asserted-by":"publisher","DOI":"10.3768\/RTIPRESS.2015.BK.0014.1509","volume-title":"Patient-reported outcomes in performance measurement","author":"D Cella","year":"2015","unstructured":"Cella D, Hahn E, Jensen S, et al. Patient-reported outcomes in performance measurement. Research Triangle Park: RTI Press; 2015. https:\/\/doi.org\/10.3768\/RTIPRESS.2015.BK.0014.1509."},{"issue":"1","key":"2183_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13023-018-0953-9","volume":"13","author":"C Pascoal","year":"2018","unstructured":"Pascoal C, Brasil S, Francisco R, et al. Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review. Orphanet J Rare Dis. 2018;13(1):215. https:\/\/doi.org\/10.1186\/s13023-018-0953-9.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2183_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1472-6963-13-211","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13(1):211. https:\/\/doi.org\/10.1186\/1472-6963-13-211.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"2183_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.2018.18085","volume":"321","author":"F Denis","year":"2019","unstructured":"Denis F, Basch E, Septans AL, et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA J Am Med Assoc. 2019;321(3):306\u20137. https:\/\/doi.org\/10.1001\/jama.2018.18085.","journal-title":"JAMA J Am Med Assoc"},{"issue":"5 SUPPL. 1","key":"2183_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, et al. The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5 SUPPL. 1):S3\u201311. https:\/\/doi.org\/10.1097\/01.mlr.0000258615.42478.55.","journal-title":"Med Care"},{"issue":"1","key":"2183_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-014-0159-8","volume":"9","author":"NA Zeltner","year":"2014","unstructured":"Zeltner NA, Huemer M, Baumgartner MR, Landolt MA. Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism\u2014a systematic review. Orphanet J Rare Dis. 2014;9(1):159. https:\/\/doi.org\/10.1186\/s13023-014-0159-8.","journal-title":"Orphanet J Rare Dis"},{"key":"2183_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2016_545","volume":"31","author":"NA Zeltner","year":"2017","unstructured":"Zeltner NA, Landolt MA, Baumgartner MR, et al. Living with intoxication-type inborn errors of metabolism: a qualitative analysis of interviews with paediatric patients and their parents. JIMD Rep. 2017;31:1\u20139. https:\/\/doi.org\/10.1007\/8904_2016_545.","journal-title":"JIMD Rep"},{"issue":"2","key":"2183_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"2183_CR13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"1","key":"2183_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13063-016-1479-x","volume":"17","author":"ST Brookes","year":"2016","unstructured":"Brookes ST, Macefield RC, Williamson PR, et al. Three nested randomized controlled trials of peer-only or multiple stakeholder group feedback within Delphi surveys during core outcome and information set development. Trials. 2016;17(1):409. https:\/\/doi.org\/10.1186\/s13063-016-1479-x.","journal-title":"Trials"},{"issue":"4","key":"2183_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395\u2013400. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.012.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2183_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1745-6215-13-132","volume":"13","author":"PR Williamson","year":"2012","unstructured":"Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13(1):132. https:\/\/doi.org\/10.1186\/1745-6215-13-132.","journal-title":"Trials"},{"issue":"5","key":"2183_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ejp.582","volume":"19","author":"V Wylde","year":"2015","unstructured":"Wylde V, Mackichan F, Bruce J, Gooberman-Hill R. Assessment of chronic post-surgical pain after knee replacement: development of a core outcome set. Eur J Pain (UK). 2015;19(5):611\u201320. https:\/\/doi.org\/10.1002\/ejp.582.","journal-title":"Eur J Pain (UK)"},{"issue":"6","key":"2183_CR18","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1177\/2374373519895680","volume":"7","author":"A Kamimura","year":"2020","unstructured":"Kamimura A, Higham R, Rathi N, Panahi S, Lee E, Ashby J. Patient-provider relationships among vulnerable patients: the association with health literacy, continuity of care, and self-rated health. J Patient Exp. 2020;7(6):1450\u20137. https:\/\/doi.org\/10.1177\/2374373519895680.","journal-title":"J Patient Exp"},{"issue":"4","key":"2183_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ymgme.2012.01.014","volume":"105","author":"SL Weber","year":"2012","unstructured":"Weber SL, Segal S, Packman W. Inborn errors of metabolism: psychosocial challenges and proposed family systems model of intervention. Mol Genet Metab. 2012;105(4):537\u201341. https:\/\/doi.org\/10.1016\/j.ymgme.2012.01.014.","journal-title":"Mol Genet Metab"},{"key":"2183_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0718-x","author":"T Morel","year":"2017","unstructured":"Morel T, Cano SJ. Measuring what matters to rare disease patients\u2014reflections on the work by the IRDiRC taskforce on patient-centered outcome measures. Orphanet J Rare Dis. 2017. https:\/\/doi.org\/10.1186\/s13023-017-0718-x.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2183_CR21","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s11136-020-02690-4","volume":"30","author":"M McNeill","year":"2021","unstructured":"McNeill M, Noyek S, Engeda E, Fayed N. Assessing the engagement of children and families in selecting patient-reported outcomes (PROs) and developing their measures: a systematic review. Qual Life Res. 2021;30(4):983\u201395. https:\/\/doi.org\/10.1007\/s11136-020-02690-4.","journal-title":"Qual Life Res"},{"issue":"9","key":"2183_CR22","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","volume":"26","author":"D Howell","year":"2015","unstructured":"Howell D, Molloy S, Wilkinson K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846\u201358. https:\/\/doi.org\/10.1093\/annonc\/mdv181.","journal-title":"Ann Oncol"},{"issue":"1","key":"2183_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/jimd.12315","volume":"44","author":"S Stockler-Ipsiroglu","year":"2021","unstructured":"Stockler-Ipsiroglu S, Potter BK, Yuskiv N, Tingley K, Patterson M, Karnebeek C. Developments in evidence creation for treatments of inborn errors of metabolism. J Inherit Metab Dis. 2021;44(1):88\u201398. https:\/\/doi.org\/10.1002\/jimd.12315.","journal-title":"J Inherit Metab Dis"},{"key":"2183_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jclinepi.2016.06.010","volume":"79","author":"BC Johnston","year":"2016","unstructured":"Johnston BC, Miller PA, Agarwal A, et al. Limited responsiveness related to the minimal important difference of patient-reported outcomes in rare diseases. J Clin Epidemiol. 2016;79:10\u201321. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.06.010.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2183_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","volume":"56","author":"S Wiebe","year":"2003","unstructured":"Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56(1):52\u201360. https:\/\/doi.org\/10.1016\/S0895-4356(02)00537-1.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2183_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/ijamh-2013-0018","volume":"25","author":"H Goldstein","year":"2013","unstructured":"Goldstein H, Akre C, Belanger RE, Suris JC. Detached, distraught or discerning? Fathers of adolescents with chronic illness: a review of the literature. Int J Adolesc Med Health. 2013;25(2):109\u201317. https:\/\/doi.org\/10.1515\/ijamh-2013-0018.","journal-title":"Int J Adolesc Med Health"},{"issue":"12","key":"2183_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","volume":"72","author":"N Duru","year":"2013","unstructured":"Duru N, Van Der Goes MC, Jacobs JWG, et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2013;72(12):1905\u201313. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203249.","journal-title":"Ann Rheum Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02183-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T12:09:41Z","timestamp":1643458181000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02183-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02183-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The usage of patient data in this study was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Patient data used in this study were all assessed and published based on informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare no competing interests but disclose the following: M.R. Baumgartner reports a research fund from Nutricia and is a member of the clinical advisory boards of Hemoshear and Moderna. M. Huemer has received research grants from Nutricia Metabolics and consultancy honoraria from SOBI, Aeglea, Shire, Sanofi, and Orphan Europe. F. B\u00f6sch, M.A. Landolt and N.A. Zeltner report that they have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}